Breaking News Instant updates and real-time market news.

POR

Portland General Electric

$40.49

0.55 (1.38%)

, ASNS

Arsanis

$12.34

-0.4389 (-3.43%)

10:20
02/15/18
02/15
10:20
02/15/18
10:20

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Portland General Electric (POR) initiated with a Buy at Mizuho. 2. Arsanis (ASNS) initiated with an Overweight at Cantor Fitzgerald. 3. Cantor says PolarityTE (COOL) can revolutionize regenerative medicine. 4. Foundation Medicine (FMI) initiated with an Outperform at Cowen. 5. Box (BOX) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

POR

Portland General Electric

$40.49

0.55 (1.38%)

ASNS

Arsanis

$12.34

-0.4389 (-3.43%)

COOL

Ticker changed to PTE

$20.30

1.1 (5.73%)

FMI

Foundation Medicine

$65.60

2.75 (4.38%)

BOX

Box

$21.61

0.41 (1.93%)

  • 16

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 14

    Mar

POR Portland General Electric
$40.49

0.55 (1.38%)

02/02/18
UBSW
02/02/18
INITIATION
Target $40
UBSW
Sell
Portland General Electric initiated with a Sell at UBS
UBS analyst Daniel Ford started Portland General Electric with a Sell rating and $40 price target.
09/19/17
LTCO
09/19/17
NO CHANGE
LTCO
Portland General Electric filing to lead to revenue increase, says Ladenburg
Ladenburg analyst Brian Russo reiterated his Buy rating and $48 price target on Portland General Electric after a stipulation was filed with the Oregon Public Utility Commission which reflects updated agreements, including with Portland General Electric, that will result in a net revenue increase.
02/14/18
MZHO
02/14/18
INITIATION
Target $14
MZHO
Buy
Portland General Electric initiated with a Buy at Mizuho
Mizuho initiated Portland General Electric with a Buy and $14 price target.
02/13/18
WELS
02/13/18
NO CHANGE
Target $42
WELS
Market Perform
Portland General Electric price target lowered to $42 from $50 at Wells Fargo
Wells Fargo analyst Sarah Akers lowered her price target for Portland General Electric to $42 from $50 ahead of year-end results reflecting tax reform updates and other developments/adjustments. The analyst reiterates a Market Perform rating on the shares.
ASNS Arsanis
$12.34

-0.4389 (-3.43%)

02/14/18
CANT
02/14/18
INITIATION
Target $26
CANT
Overweight
Arsanis initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated Arsanis with an Overweight and $26 price target.
02/15/18
CANT
02/15/18
INITIATION
Target $26
CANT
Overweight
Arsanis initiated with Overweight, $26 price target at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen last night initiated Arsanis with an Overweight rating and $26 price target. The analyst sees catalysts driving the stock higher as the company advances its pipeline towards commercialization. She believes Arsanis is well positioned to become a leader in monoclonal antibodies immunotherapy for treating infections.
12/11/17
SBSH
12/11/17
INITIATION
Target $27
SBSH
Buy
Arsanis initiated with a Buy at Citi
Citi analyst Joel Beatty started Arsanis with a Buy rating and $27 price target. The analyst feels the timing is right to bring monoclonal antibodies to infectious disease.
12/11/17
12/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Market Perform on valuation at Cowen. 2. Illinois Tool Works (ITW) initiated with a Buy at BofA/Merrill. 3. SendGrid (SEND) was initiated with an Outperform at William Blair, an Overweight at Piper Jaffray, KeyBanc, and JPMorgan, a Buy at Stifel, as well as an Equal Weight at Morgan Stanley. 4. BWX Technologies (BWXT) initiated with a Market Perform at Wells Fargo. 5. Arsanis (ASNS) was initiated with an Overweight at Piper Jaffray, an Outperform at Cowen, and a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
COOL Ticker changed to PTE
$20.30

1.1 (5.73%)

02/14/18
CANT
02/14/18
INITIATION
Target $70
CANT
Overweight
PolarityTE initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated PolarityTE with an Overweight and $70 price target.
02/15/18
CANT
02/15/18
INITIATION
Target $70
CANT
Overweight
Cantor says PolarityTE can revolutionize regenerative medicine
Cantor Fitzgerald analyst Elemer Piros last night initiated PolarityTE with an Overweight rating and $70 price target. The analyst believes the company can revolutionize the field of regenerative medicine. He thinks PolarityTE's SkinTE autologous cell product can achieve $600M of sales in wound healing and potentially "multiples of this number" when adding the bone, cartilage, heart and muscle products in development.
FMI Foundation Medicine
$65.60

2.75 (4.38%)

02/15/18
COWN
02/15/18
INITIATION
Target $90
COWN
Outperform
Foundation Medicine initiated with an Outperform at Cowen
Cowen analyst Doug Schenkel started Foundation Medicine with an Outperform rating and $90 price target. The company is the "uniquely positioned" leader in comprehensive cancer profiling, Schenkel tells investors in a research note. He believes Foundation's clinical volumes are likely to accelerate following the recent CMS/FDA dual path approval.
04/03/17
WBLR
04/03/17
NO CHANGE
WBLR
Outperform
William Blair sees more upside for Foundation Medicine despite recent rally
After revisiting her thesis with the stock up 82% year-to-date, William Blair analyst Amanda Murphy continues to see potential for upside in Foundation Medicine shares. The analyst is unable to pinpoint a specific catalyst for the move higher, but notes short covering likely played a role while reimbursement fundamentals appear to have shifted in the company's favor over the past few weeks. The analyst sees potential for 20%-30% in compound annual revenue growth over the next five years for Foundation and keeps an Outperform rating on the name.
01/29/18
GSCO
01/29/18
INITIATION
Target $73
GSCO
Neutral
Foundation Medicine initiated with a Neutral at Goldman Sachs
Goldman analyst Patrick Donnelly initiated Foundation Medicine with a Neutral and $73 price target.
05/15/17
BTIG
05/15/17
UPGRADE
Target $39
BTIG
Buy
Foundation Medicine upgraded to Buy from Neutral at BTIG
BTIG analyst Karen Koski upgraded Foundation Medicine to Buy from Neutral and established a $39 price target. The analyst expects Foundation to continue to benefit from educational efforts in the community setting, progress in CMS reimbursement, expanded product portfolio, and focus on improving clinical actionability of CGP.
BOX Box
$21.61

0.41 (1.93%)

11/30/17
ADAM
11/30/17
NO CHANGE
Target $25
ADAM
Buy
Box weakness a buying opportunity, says Canaccord
Canaccord analyst Richard Davis noted Box shares sold off following its Q3 earnings report as investors chose to lock in profits after its run this year. The analyst believes the stock reaction is "overwrought" given its results and guidance and he would be a buyer as he believes the shares should rally back. Davis reiterated his Buy rating and $25 price target on Box shares.
01/04/18
BOFA
01/04/18
NO CHANGE
BOFA
BofA/Merrill Endeavor List changes
BofA/Merill added Jeld-Wen (JELD) and Box (BOX) and removed Third Point Reinsurance (TPRE) and Advanced Energy (AEIS) from the Endeavor List.
11/30/17
JMPS
11/30/17
NO CHANGE
Target $25
JMPS
Outperform
Box price target raised to $25 from $22 at JMP Securities
JMP Securities analyst Greg McDowell said that despite Box's "disappointing" big deal metrics the company reported a "solid" quarter overall. He blames the company's big deal commentary and Q4 guidance that bracketed consensus for the afterhours weakness in the stock, though he continues to recommend Box shares given the company's long runway for growth, weakening competition and leverage in its model. McDowell raised his price target on the stock to $25 after earnings and keeps an Outperform rating on Box shares.
02/15/18
DADA
02/15/18
INITIATION
Target $25
DADA
Buy
Box initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated Box with a Buy rating and a price target of $25. Jaluria believes the company can sustain a high growth rate on continued cross-selling of new products such as Box KeySafe and operational leverage of its business model. The analyst also notes improvement in competitive environment for Box, with some competing vendors leaving the market and others de-emphasizing their ECM offerings.

TODAY'S FREE FLY STORIES

CVS

CVS Health

$57.40

1.23 (2.19%)

18:34
03/21/19
03/21
18:34
03/21/19
18:34
Hot Stocks
CVS Health CEO: Off to great start with Aetna integration »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.63

3.19 (1.13%)

18:30
03/21/19
03/21
18:30
03/21/19
18:30
Periodicals
EU to offer U.K. Brexit negotiating period extension, Reuters says »

The EU plans to grant the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.63

3.19 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOK

Nokia

$6.26

-0.03 (-0.48%)

18:20
03/21/19
03/21
18:20
03/21/19
18:20
Periodicals
Nokia not planning to take on new business in Iran in 2019, Reuters says »

Nokia said it does not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

DNR

Denbury Resources

$1.95

0.06 (3.17%)

, PVAC

Penn Virginia

$54.29

1.74 (3.31%)

18:17
03/21/19
03/21
18:17
03/21/19
18:17
Hot Stocks
Denbury Resources: Penn Virginia deal was unlikely to receive majority approval »

Chris Kendall,…

DNR

Denbury Resources

$1.95

0.06 (3.17%)

PVAC

Penn Virginia

$54.29

1.74 (3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 17

    Apr

  • 07

    May

IMMP

Immutep

$2.40

-0.095 (-3.82%)

18:11
03/21/19
03/21
18:11
03/21/19
18:11
Hot Stocks
Immutep announces U.S. patent for Eftilagimod Alpha in cancer »

Immutep Limited is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVAC

Penn Virginia

$54.29

1.74 (3.31%)

, DNR

Denbury Resources

$1.95

0.06 (3.17%)

18:08
03/21/19
03/21
18:08
03/21/19
18:08
Hot Stocks
Penn Virginia, Denbury Resources mutually agree to terminate merger pact »

Penn Virginia (PVAC)…

PVAC

Penn Virginia

$54.29

1.74 (3.31%)

DNR

Denbury Resources

$1.95

0.06 (3.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 17

    Apr

  • 07

    May

LLL

L3 Technologies

$208.75

1.535 (0.74%)

17:44
03/21/19
03/21
17:44
03/21/19
17:44
Hot Stocks
L3 Technologies awarded $131.78M Air Force contract »

L3 Technologies has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 01

    May

GM

General Motors

$37.35

0.35 (0.95%)

17:42
03/21/19
03/21
17:42
03/21/19
17:42
Periodicals
GM to invest $300M in Orion EV/AV factory, Reuters reports »

General Motors intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 30

    Apr

GD

General Dynamics

$169.81

1.21 (0.72%)

17:42
03/21/19
03/21
17:42
03/21/19
17:42
Hot Stocks
General Dynamics awarded $465.15M Navy contract for CVN shipyard availabilities »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

NKE

Nike

$88.05

1.3597 (1.57%)

17:41
03/21/19
03/21
17:41
03/21/19
17:41
Earnings
Breaking Earnings news story on Nike »

Nike sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

NKE

Nike

$88.05

1.3597 (1.57%)

17:39
03/21/19
03/21
17:39
03/21/19
17:39
Earnings
Nike sees Q4 revenue growth in high single-digit range, consensus $10.38B »

Sees Q4 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

NKE

Nike

$88.05

1.3597 (1.57%)

17:36
03/21/19
03/21
17:36
03/21/19
17:36
Hot Stocks
Nike says it is not taking China momentum for granted »

Says leveraging the power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

LOV

Spark Networks

$11.29

(0.00%)

17:34
03/21/19
03/21
17:34
03/21/19
17:34
Hot Stocks
Spark Networks to acquire Zoosk, sees adjusted EBITDA to exceed $50M in 2020 »

Spark Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACA

Arcosa

$29.74

-0.16 (-0.54%)

17:29
03/21/19
03/21
17:29
03/21/19
17:29
Initiation
Arcosa initiated at DA Davidson »

Arcosa initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$138.09

0.86 (0.63%)

17:24
03/21/19
03/21
17:24
03/21/19
17:24
Hot Stocks
Johnson & Johnson sees Q1 charge of about $700M related to AL-8176 »

On March 21, Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 25

    Apr

LPI

Laredo Petroleum

$3.33

0.045 (1.37%)

17:19
03/21/19
03/21
17:19
03/21/19
17:19
Syndicate
Breaking Syndicate news story on Laredo Petroleum »

Laredo Petroleum files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$88.05

1.3597 (1.57%)

17:15
03/21/19
03/21
17:15
03/21/19
17:15
Hot Stocks
Nike says NBA sponsorship is tracking to be its largest merchandising deal »

Says China has earned 19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

ULTA

Ulta Beauty

$335.02

4.31 (1.30%)

17:05
03/21/19
03/21
17:05
03/21/19
17:05
Conference/Events
Ulta Beauty management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

ZYXI

Zynex

$4.45

0.02 (0.45%)

17:04
03/21/19
03/21
17:04
03/21/19
17:04
Hot Stocks
Zynex chairman Thomas Sandgaard sells over 48K shares of company stock »

Zynex chairman Thomas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JE

Just Energy

$3.46

0.02 (0.58%)

17:02
03/21/19
03/21
17:02
03/21/19
17:02
Hot Stocks
Just Energy cuts over 200 jobs, to incur $9M in severances costs in 4Q19 »

Just Energy announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GORO

Gold Resource

$3.95

0.01 (0.25%)

17:02
03/21/19
03/21
17:02
03/21/19
17:02
Hot Stocks
Gold Resource's Mirador Mine development assayed 992 grams per tonne silver »

Gold Resource announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

PLCE

Children's Place

$87.50

-0.44 (-0.50%)

17:01
03/21/19
03/21
17:01
03/21/19
17:01
Hot Stocks
Children's Place raises quarterly dividend 12% to 56c per share »

The Children's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 02

    Apr

PNC

PNC Financial

$122.90

-2.56 (-2.04%)

16:59
03/21/19
03/21
16:59
03/21/19
16:59
Conference/Events
PNC Financial management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 12

    Apr

  • 23

    Apr

  • 17

    Jul

  • 16

    Oct

BHB

Bar Harbor Bankshares

$24.04

-0.31 (-1.27%)

16:56
03/21/19
03/21
16:56
03/21/19
16:56
Hot Stocks
Bar Harbor Bankshares authorizes stock repurchase plan of up to 5% »

Bar Harbor Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

16:55
03/21/19
03/21
16:55
03/21/19
16:55
Conference/Events
BMW management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.